Can a Lower-Dose radiation 'Rotisserie' treatment ease skin lymphoma symptoms?
NCT ID NCT02702310
First seen Aug 19, 2026 · Last updated Aug 19, 2026
Summary
This trial is testing whether low-dose total skin electron therapy, given while a person stands on a rotating platform, can improve quality of life for people with mycosis fungoides that has returned or not responded to prior treatment. Participants receive standard radiation care and fill out questionnaires about how their skin condition affects daily life. The study also tracks how well the skin responds to treatment over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Low-dose total skin electron therapy using the rotisserie technique
- What this could lead to
- If it works, this could offer a gentler, repeatable radiation option that improves quality of life for people with mycosis fungoides.
- What could go wrong
- This is an observational trial, so it won't prove the treatment works better than other options. Side effects from radiation are still possible, and results may vary.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT MYCOSIS FUNGOIDES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New combo shows promise for rare blood cancer
- Two-Drug attack on tough lymphoma shows promise in early trial
- Experimental antibody takes aim at tough lymphoma
- Engineered virus targets Hard-to-Treat blood cancers in new trial
- Immunotherapy and chemo join forces against tough lymphoma
- Rash or remission? new study aims to decode drug side effect in rare skin cancers